Literature DB >> 359134

Unique steroid congeners for receptor studies.

T Ojasoo, J P Raynaud.   

Abstract

To determine the hormone-dependence of a tumor, it is preferable to use highly specific radiolabeled ligands when available, since often more than one class of steroid hormone receptor is present in the tissue specimen, and interference from classes other than the one under study cannot be readily eliminated. In this study, we describe a simple in vitro system used to define the molecular requirements for a highly specific interaction between a steroid and the receptor corresponding to a single class of hormone. It is based on the use of homogenate or crude 105,000 X g supernatant prepared from the target organs considered as end points in routine biological potency tests and on the use of available radioligands not bound by plasma proteins (tags) to single out the receptors. For each receptor singled out in the target organ cytoplasm, the ability of over 700 molecules to decrease bound radioactivity was compared to that of the natural hormone (relative binding affinity) with the use of a dextran-coated charcoal technique to separate bound from unbound steroid. On the basis of the results on 81 molecules, presented in this study, the effect of various substituents on the affinity and specificity of the natural hormones was determined. Molecules interacting markedly with several receptors were submitted to X-ray crystallography in order to establish whether overlap between the various conformations of the natural hormone and of the test molecule might not partly account for lack of specificity.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 359134

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  9 in total

1.  Photocytotoxicity of the fluorescent nonsteroidal androgen receptor ligand TDPQ.

Authors:  Piotr J Bilski; Boris Risek; Colin F Chignell; William T Schrader
Journal:  Photochem Photobiol       Date:  2009-05-28       Impact factor: 3.421

2.  [Ultrastructural localization of estradiol and moxestrol in the gonadotropic cells of rat by immunocytology after cryo-ultramicrotomy: evidence for hormonal specificity (author's transl)].

Authors:  G Morel; J P Raynaud; P M Dubois
Journal:  Experientia       Date:  1981-01-15

3.  Characterization of human androgen receptor overexpressed in the baculovirus system.

Authors:  C Chang; C Wang; H F DeLuca; T K Ross; C C Shih
Journal:  Proc Natl Acad Sci U S A       Date:  1992-07-01       Impact factor: 11.205

4.  Progesterone and RU486: opposing effects on human sperm.

Authors:  J Yang; C Serres; D Philibert; P Robel; E E Baulieu; P Jouannet
Journal:  Proc Natl Acad Sci U S A       Date:  1994-01-18       Impact factor: 11.205

5.  Steroid hormone receptors in human meningiomas, gliomas and brain metastases.

Authors:  M Poisson; B F Pertuiset; J J Hauw; J Philippon; A Buge; M Moguilewsky; D Philibert
Journal:  J Neurooncol       Date:  1983       Impact factor: 4.130

6.  Androgen- and estrogen-receptor content in spontaneous and experimentally induced canine prostatic hyperplasia.

Authors:  J Trachtenberg; L L Hicks; P C Walsh
Journal:  J Clin Invest       Date:  1980-05       Impact factor: 14.808

7.  Simultaneous micro measurement of steroid receptors in breast cancer.

Authors:  G Milano; J L Moll; J L Formento; M Francoual; B P Krebs; M Namer; J L Boublil; C M Lalanne
Journal:  Br J Cancer       Date:  1983-10       Impact factor: 7.640

Review 8.  PET Imaging Agents (FES, FFNP, and FDHT) for Estrogen, Androgen, and Progesterone Receptors to Improve Management of Breast and Prostate Cancers by Functional Imaging.

Authors:  John A Katzenellenbogen
Journal:  Cancers (Basel)       Date:  2020-07-23       Impact factor: 6.639

9.  Immunofluorescent detection of hormone receptors in cutaneous melanocytic tumours.

Authors:  A J Thompson; M G Cook; P G Gill
Journal:  Br J Cancer       Date:  1981-05       Impact factor: 7.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.